Your session is about to expire
← Back to Search
Stress First Aid for COVID-19 Frontline Health Care Workers (COVER-HCW Trial)
COVER-HCW Trial Summary
This trial will help support the mental and physical well-being of US health care workers during the COVID-19 pandemic.
- Healthy Subjects
COVER-HCW Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COVER-HCW Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Stress First Aid
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the principal goal of this medical study?
"This clinical trial, which is set to take place over two months, aims to reduce the prevalence of Post-Traumatic Stress Disorder (PTSD). Additional goals include improving resilience as measured by Connor Davidson Resilience Scale (CDRISC), reducing workplace stress according to American Psychological Association's Stress in the Workplace survey and assessing burnout with Dolan single item burnout inventory."
Are there any vacancies for participants in this experiment?
"According to clinicaltrials.gov, this research effort is still taking applications from volunteers who wish to participate in the trial. The study was first launched on March 11th 2021 and its information has been recently refreshed on October 24 2022."
How many participants can potentially be enrolled in this research?
"Affirmative. Online records on clinicaltrials.gov make clear that this scientific experiment has commenced patient recruitment, which began on March 11th 2021 and is still ongoing after the most recent edit made on October 24th 2022. In total, 2132 individuals are required to take part in this single-site trial."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger